Menopausal hormone therapy: What we know now

American Journal of Nursing

Volumn 111, Issue 6, 2011, Pages 38-47

  Roush, Karen ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

bioidentical hormones; combined estrogen and progestogen therapy; estrogen; estrogen therapy; hormone therapy; menopausal transition; menopause; postmenopause; progestin; progestogen; women's health; Women's Health Initiative

Indexed keywords

ESTROGEN;

ARTICLE; DECISION MAKING; ESTROGEN THERAPY; EVIDENCE BASED NURSING; FEMALE; HUMAN; MEDICAL RESEARCH; MENOPAUSE; METHODOLOGY; NURSING; PRACTICE GUIDELINE; RISK ASSESSMENT; UNITED STATES;

BIOMEDICAL RESEARCH; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED NURSING; FEMALE; HUMANS; MENOPAUSE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; UNITED STATES;

EID: 79958159744     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000398539.52283.55     Document Type: Article

References (59)

1. Centers for Disease Control and Prevention. Women's reproductive health: menopause. 2009. http://www.cdc.gov/Reproductivehealth/WomensRH/Menopause.htm.
2. Wilson RA. The obsolete menopause. Del Med J 1964;36:20-1.
3. Wilson RA, et al. Specific procedures for the elimination of the menopause. West J Surg Obstet Gynecol 1963;71(1):110-21.
4. Wilson RA, Wilson TA. The fate of the nontreated postmenopausal woman: a plea for the maintenance of adequate estrogen from puberty to the grave. J Am Geriatr Soc 1963;11:347-62.
5. Kennedy DL, et al. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985;65(3):441-6. (Pubitemid 15134677)
6. Smith DC, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975;293(23):1164-7.
7. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975;293(23):1167-70.
8. Gambrell RD, Jr. Hormones in the etiology and prevention of breast and endometrial cancer. South Med J 1984;77(12):1509-15.
9. Gambrell RD, Jr., et al. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens. J Am Geriatr Soc 1979;27(9):389-94. (Pubitemid 9251431)
10. Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33. (Pubitemid 34761611)
11. Simon JA, et al. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation. Maturitas 2010;66(3):277-84.
12. National Heart, Lung and Blood Institute. Women's health initiative [landing page]. National Institutes of Health. 2010. http://www.nhlbi.nih.gov/ whi.
13. Anderson GL, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291(14):1701-12. (Pubitemid 38489892)
14. Alving B. NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase. South Med J 2004;97(4):425-6. (Pubitemid 38478770)
15. Grady D, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117(12):1016-37.
16. Stampfer MJ, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325(11):756-62.
17. Colditz GA, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332(24):1589-93.
18. Gapstur SM, et al. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA 1999;281(22):2091-7.
19. Magnusson C, et al. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999;81(3):339-44. (Pubitemid 29165190)
20. Hersh AL, et al. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291(1):47-53. (Pubitemid 38040534)
21. Heiss G, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008;299(9):1036-45. (Pubitemid 351347060)
22. Espeland MA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291(24):2959-68. (Pubitemid 38802685)
23. Rapp SR, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289(20):2663-72. (Pubitemid 37430137)
24. Manson JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356(25):2591-602. (Pubitemid 46961004)
25. Manson JE, Bassuk SS. Invited commentary: hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause? Am J Epidemiol 2007;166(5):511-7. (Pubitemid 47283647)
26. Matthews KA, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143(10):971-8. (Pubitemid 26140324)
27. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 2007;166(5):506-10. (Pubitemid 47283648)
28. Rossouw JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297(13):1465-77. (Pubitemid 46556472)
29. Naftolin F, et al. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004;81(6):1498-501. (Pubitemid 38748989)
30. Rosano GM, et al. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. J Cardiovasc Med (Hagerstown) 2009;10(1):85-92.
31. Herrington DM, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343(8):522-9. (Pubitemid 30650747)
32. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340(23):1801-11. (Pubitemid 29266405)
33. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53(3):605-19. (Pubitemid 34175253)
34. Banks E, Canfell K. Invited commentary: hormone therapy risks and benefits-the Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol 2009;170(1):24-8.
35. Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Women and heart disease fact sheet. 2010. http://www.cdc.gov/dhdsp/data-statistics/fact-sheets/fs-women-heart.htm.
36. Manson JE, et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006;13(1):139-47.
37. Centers for Disease Control and Prevention. Breast cancer: rates of new cases and deaths. 2010. http://www.cdc.gov/features/dsbreastcancertrends.
38. Alkjaersig N, et al. Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration. J Lab Clin Med 1988;111(2):224-8. (Pubitemid 18074327)
39. Scarabin PY, et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997;17(11):3071-8.
40. Canonico M, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115(7):840-5. (Pubitemid 46294724)
41. Canonico M, et al. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol 2010;30(2):340-5.
42. Renoux C, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;340:c2519.
43. Harman SM, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005;8(1):3-12. (Pubitemid 40675116)
44. Hulley SB, Grady D. The WHI estrogen-alone trial-do things look any better? JAMA 2004;291(14):1769-71. (Pubitemid 38489899)
45. Cobin RH, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract 2006;12(3):315-37.
46. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause 2010;17(2):242-55.
47. Bonds DE, et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006;49(3):459-68. (Pubitemid 43277868)
48. Hlatky MA, et al. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287(5):591-7. (Pubitemid 34252010)
49. Lethaby A, et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2008(1):CD003122.
50. Hays J, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348(19):1839-54. (Pubitemid 36532310)
51. Sauerbronn AV, et al. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000;68(1):35-41.
52. Youn CS, et al. Effect of pregnancy and menopause on facial wrinkling in women. Acta Derm Venereol 2003;83(6):419-24. (Pubitemid 37475781)
53. Endocrine Society. Position statement. Bioidentical hormones. Chevy Chase, MD; 2006 Oct. http://www.menopause.org/bioidenticalHT-Endosoc.pdf.
54. U.S. Food and Drug Administration. For consumers: bio-identicals: sorting myths from facts. 2008. http://www.fda.gov/ForConsumers/ConsumerUpdates/ ucm049311.htm.
55. Borsage PM, Freeman S. Bioidentical hormones, compounding, and evidence-based medicine: what women's health practitioners need to know. J Nurse Pract 2009;5(6):421-7.
56. Cirigliano M. Bioidentical hormone therapy: a review of the evidence. J Womens Health (Larchmt) 2007;16(5):600-31. (Pubitemid 47093906)
57. Patsner B. Bioidentical hormone therapy: what's the harm? Mayfield Heights, OH: North American Menopause Society; 2008. http://www.menopause.org/ bioidentical.aspx.
58. Maclennan AH, et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004(4):CD002978.
59. Nelson HD. Postmenopausal estrogen for treatment of hot flashes: clinical applications. JAMA 2004;291(13):1621-5. (Pubitemid 38552435)